CellGenix® rh TGF-β1 (Preclinical Grade)
Top Features for Recombinant Transforming Growth Factor-beta 1:
- Optimal use of expansion of HSC's
- ADCF Level 2
- High purity to ensure the safety of your process
- Available in two different grades (Preclinical and GMP grade)
Preclinical grade:
- Intended for preclinical ex vivo use
- Endotoxin Level ≤ 10 EU/mg
- GMP transferable: Seamless transition from preclinical development to commercial manufacturing
GMP grade:
- Intended for clinical ex vivo use
- Endotoxin Level ≤ 10 EU/mg
- Manufactured in accordance with applicable GMP guidelines
- FDA Drug Master File (DMF) available
- Technical and regulatory support available
- Price (USD):
- $1,040.00
- Item No.:
- 1426-050
*Custom/bulk order quotes are provided within 72 hours of request.
Letter of Authorization (LOA)
Place a request for a Letter of Authorization (LOA) for our Drug Master File (FDA)
CellGenix® rh Cytokines - Preclinical vs GMP
Both product grades are produced under the same conditions in a GMP facility, ensuring an equal product quality and performance. We offer a more comprehensive QC testing including tighter specifications and documentation for our GMP products: CellGenix® rh Cytokines - Preclinical vs GMP
"
CellGenix® Preclinical Recombinant Human Transforming Growth Factor-beta 1 (TGF-β1) is an animal-derived component-free product. It is produced in a dedicated animal-free GMP facility.
TGF-β1 is used in the cell and gene therapy space to promote expansion of induced pluripotent stem cells (iPSCs), embryonic stem cells (ESCs), mesenchymal stem cells (MSCs) and regulatory T cells (Tregs). CellGenix® Recombinant Human TGF-β1 is produced using a human amniocyte cell line (CAP®) to enable authentic human post-translational modifications.
CAP® is a registered trademark of CEVEC Pharmaceuticals GmbH, Germany.
Designed to meet the demands of translational research, CellGenix® preclinical cytokines are ideal to bridge the gap between the lower quality of research grade and the high cost of GMP grade materials.
Please access the Certificate of Analysis on the My Sartorius Portal.
Expiry: 3 years from date of shipping
"
Datasheet
Safety Datasheet
Technical Note
Applications
-
ApplicationPreclinical ex vivo use
-
Application Area
-
Cell & gene therapy
- Immunology
-
Cell & gene therapy
-
Cell Type
-
MSC
-
T Cells
-
ESC/iPSC
- Organoids
-
MSC
Biological Information
-
Activity≥ 9 x 106 IU/mg
Compliance Information
-
OriginAnimal-Component Free
Features
-
Carrier-Protein FreeYes
Physicochemical Information
-
Endotoxin≤ 1 EU/µg
-
Expression SystemCAP® cell line
Product Information
-
BrandCellGenix®
-
Package TypeVial
-
Size50 µg
Sterility/Purity
-
Delivery ConditionSterile
-
Purity≥ 95%
Weight
-
Molecular Weight (kDa)25.6 kDa